The Blood and Marrow Transplant (BMT) Program at Cleveland Clinic provides high quality specialized patient care in a setting of innovative research and education. The BMT Program at Cleveland Clinic has performed greater than 6,000 transplants over the last 40 years. Our team includes board-certified specialists with the training and experience necessary to treat a broad range of blood cancers and conditions with transplantation and cellular therapies. Our BMT team works closely with other Cleveland Clinic experts such as radiation oncologists, transplant coordinators, nurse practitioners, and pharmacists to create personalized treatment plans for our patients. We offer all the latest FDA-approved cellular therapies, including chimeric antigen receptor T-cell (CAR T) therapy. The BMT Program at Cleveland Clinic has recently infused approximately 100 CAR T therapies annually. We also offer our BMT patients the Victor Fazio, MD BMT Cancer Survivorship Clinic which is dedicated to maintaining our patients’ routine health and education, screening, prevention, and treatment of long-term side effects from their transplants.